Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy

Vaccinia virus (VACV) oncolytic therapy has been successful in a number of tumor models. In this study our goal was to generate a double recombinant vaccinia virus (VV-GMCSF-Lact) with enhanced antitumor activity that expresses exogenous proteins: the antitumor protein lactaptin and human granulocyt...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Kochneva, Galina, Sivolobova, Galina, Tkacheva, Anastasiya, Grazhdantseva, Antonina, Troitskaya, Olga, Nushtaeva, Anna, Tkachenko, Anastasiya, Kuligina, Elena, Richter, Vladimir, Koval, Olga
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2016
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342044/
https://ncbi.nlm.nih.gov/pubmed/27708236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12367
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky